Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
Clinical trial NCT02687451 · TERMINATED
Trial details
- NCT number
- NCT02687451
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.